GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Cyclically Adjusted Revenue per Share

Hwail Pharm Co (XKRX:061250) Cyclically Adjusted Revenue per Share : ₩2,447.77 (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Hwail Pharm Co's adjusted revenue per share for the three months ended in Mar. 2024 was ₩496.604. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩2,447.77 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Hwail Pharm Co's average Cyclically Adjusted Revenue Growth Rate was -1.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Hwail Pharm Co was 1.80% per year. The lowest was -1.50% per year. And the median was -0.90% per year.

As of today (2024-05-26), Hwail Pharm Co's current stock price is ₩1557.00. Hwail Pharm Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩2,447.77. Hwail Pharm Co's Cyclically Adjusted PS Ratio of today is 0.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hwail Pharm Co was 2.23. The lowest was 0.64. And the median was 0.97.


Hwail Pharm Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Hwail Pharm Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Cyclically Adjusted Revenue per Share Chart

Hwail Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,549.52 2,394.02 2,428.24 2,482.86 2,468.63

Hwail Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,486.89 2,469.65 2,493.60 2,468.63 2,447.77

Competitive Comparison of Hwail Pharm Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hwail Pharm Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hwail Pharm Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hwail Pharm Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hwail Pharm Co's Cyclically Adjusted PS Ratio falls into.



Hwail Pharm Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hwail Pharm Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=496.604/118.8477*118.8477
=496.604

Current CPI (Mar. 2024) = 118.8477.

Hwail Pharm Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 570.774 99.353 682.769
201409 529.347 99.608 631.593
201412 683.534 99.098 819.759
201503 592.216 99.720 705.811
201506 637.637 100.050 757.438
201509 692.142 100.110 821.691
201512 701.126 100.220 831.443
201603 775.511 100.560 916.544
201606 719.658 100.790 848.593
201609 646.050 101.460 756.767
201612 607.585 101.560 711.009
201703 685.749 102.850 792.413
201706 756.289 102.610 875.969
201709 627.298 103.490 720.388
201712 570.261 102.990 658.066
201803 620.736 104.100 708.675
201806 661.285 104.130 754.751
201809 602.213 105.650 677.441
201812 635.219 104.350 723.472
201903 619.992 104.490 705.183
201906 622.171 104.880 705.030
201909 662.931 105.200 748.934
201912 633.863 105.120 716.640
202003 247.311 105.540 278.495
202006 224.557 104.870 254.487
202009 180.275 106.200 201.745
202012 145.733 105.765 163.759
202103 405.140 107.357 448.502
202106 377.288 107.579 416.810
202109 409.637 108.759 447.635
202112 478.469 109.676 518.479
202203 470.457 111.806 500.088
202206 539.642 114.083 562.181
202209 523.763 114.831 542.082
202212 474.178 115.200 489.192
202303 473.650 116.550 482.989
202306 496.235 117.140 503.470
202309 436.100 119.111 435.135
202312 465.683 118.848 465.683
202403 496.604 118.848 496.604

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Hwail Pharm Co  (XKRX:061250) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hwail Pharm Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1557.00/2447.77
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hwail Pharm Co was 2.23. The lowest was 0.64. And the median was 0.97.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Hwail Pharm Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hwail Pharm Co (XKRX:061250) Business Description

Industry
Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines